24/7 Market News Snapshot 26 June, 2025 – NanoVibronix, Inc. Common Stock (NASDAQ:NAOV)

June 26, 2025

DENVER, Colo., 26 June, 2025 (www.247marketnews.com) – (NASDAQ:NAOV) are discussed in this article.
NanoVibronix, Inc. (NASDAQ:NAOV) is experiencing a significant upswing in its stock performance, with shares reaching a current trading price of $1.287, marking an increase of over 46% from an opening price of $0.87. This remarkable activity is underscored by a notable trading volume of 10.84 million shares, reflecting heightened investor interest and confidence in the company’s innovative solutions.

In conjunction with this momentum in the stock market, NanoVibronix has unveiled its groundbreaking ENvue Drive™ platform within its ENvue Medical division. This state-of-the-art robotic development aims to revolutionize the automation of electromagnetic navigation for enteral and vascular access procedures, thereby enhancing clinical efficiency and elevating patient care standards. With increasing demands for procedural volume amidst workforce challenges, ENvue Drive will integrate with the company’s FDA-cleared electromagnetic guidance technology to provide automated alignment and positional stability during critical medical procedures.

Dr. Doron Besser, CEO of NanoVibronix, emphasized that this initiative marks a pivotal advancement in bedside clinical care, enabling healthcare professionals to perform safe, precise, and reliable treatments in high-demand environments. The launch follows a robust second quarter for NanoVibronix, which included strategic partnerships, novel developments, and a new patent for pediatric applications.

Currently in the preclinical development phase, ENvue Drive’s engineering prototypes are in progress, with regulatory planning and submission processes anticipated later this year. The expected delivery of a functional prototype by year-end positions NanoVibronix well to capitalize on the growing global market for enteral feeding and vascular access devices.

Through the innovative ENvue Drive, NanoVibronix is reaffirming its commitment to advancing healthcare technology while striving to improve patient outcomes across various clinical settings.

Related news for (NAOV)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.